WO2010137875A3 - 콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물 - Google Patents

콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물 Download PDF

Info

Publication number
WO2010137875A3
WO2010137875A3 PCT/KR2010/003335 KR2010003335W WO2010137875A3 WO 2010137875 A3 WO2010137875 A3 WO 2010137875A3 KR 2010003335 W KR2010003335 W KR 2010003335W WO 2010137875 A3 WO2010137875 A3 WO 2010137875A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition containing
blood circulation
bean extract
improving blood
vascular health
Prior art date
Application number
PCT/KR2010/003335
Other languages
English (en)
French (fr)
Other versions
WO2010137875A2 (ko
Inventor
신현정
김진관
김채욱
주경미
정연수
임경민
서대방
주영협
이상준
박영호
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to CN201080032432.0A priority Critical patent/CN102802652B/zh
Priority to US13/322,381 priority patent/US20120070520A1/en
Priority to JP2012512969A priority patent/JP2012528146A/ja
Publication of WO2010137875A2 publication Critical patent/WO2010137875A2/ko
Publication of WO2010137875A3 publication Critical patent/WO2010137875A3/ko
Priority to US16/266,658 priority patent/US11197903B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)

Abstract

본 발명은 저농도 저급 알코올로 추출한 콩 추출물 또는 그 분획물을 함유하는 조성물에 관한 것이다. 상기 조성물은 혈액 순환 개선 효과가 우수하고, 비만 상태를 개선시키며, 당뇨 및 고질혈증 등의 예방, 증상의 완화 또는 치료에 효과적이다.
PCT/KR2010/003335 2009-05-26 2010-05-26 콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물 WO2010137875A2 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN201080032432.0A CN102802652B (zh) 2009-05-26 2010-05-26 用于促进血液循环和增强血管健康的包含豆类提取物的组合物
US13/322,381 US20120070520A1 (en) 2009-05-26 2010-05-26 Composition containing a bean extract for improving blood circulation and increasing vascular health
JP2012512969A JP2012528146A (ja) 2009-05-26 2010-05-26 豆抽出物を含有する血液循環改善及び血管健康増進用組成物
US16/266,658 US11197903B2 (en) 2009-05-26 2019-02-04 Composition containing a bean extract for improving blood circulation and vascular health and method for improving blood circulation and vascular health

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090046107 2009-05-26
KR10-2009-0046107 2009-05-26

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/322,381 A-371-Of-International US20120070520A1 (en) 2009-05-26 2010-05-26 Composition containing a bean extract for improving blood circulation and increasing vascular health
US16/266,658 Division US11197903B2 (en) 2009-05-26 2019-02-04 Composition containing a bean extract for improving blood circulation and vascular health and method for improving blood circulation and vascular health

Publications (2)

Publication Number Publication Date
WO2010137875A2 WO2010137875A2 (ko) 2010-12-02
WO2010137875A3 true WO2010137875A3 (ko) 2011-04-14

Family

ID=43223244

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/003335 WO2010137875A2 (ko) 2009-05-26 2010-05-26 콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물

Country Status (5)

Country Link
US (2) US20120070520A1 (ko)
JP (2) JP2012528146A (ko)
KR (2) KR101876471B1 (ko)
CN (1) CN102802652B (ko)
WO (1) WO2010137875A2 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110138001A (ko) * 2010-06-18 2011-12-26 (주)아모레퍼시픽 유색콩 추출물을 함유하는 조성물
KR20110138000A (ko) * 2010-06-18 2011-12-26 (주)아모레퍼시픽 유색콩 추출물을 함유하는 조성물
KR20120089045A (ko) * 2011-02-01 2012-08-09 주식회사 케이오씨바이오텍 새콩 분말 또는 이의 추출물을 포함하는 당뇨병 및 당뇨합병증 예방 및 치료를 위한 조성물
WO2012138146A2 (ko) * 2011-04-08 2012-10-11 주식회사 케이오씨바이오텍 돌콩의 열처리분말 또는 추출물을 유효성분으로 하는 당뇨병 및 당뇨합병증의 예방 및 치료를 위한 조성물
KR101178947B1 (ko) * 2011-04-29 2012-09-03 한국생명공학연구원 올레아놀린산 아세테이트를 유효성분으로 포함하는 ｔｌｒ 및 ｉｌ-6 매개성 질환 예방 또는 치료용 약학적 조성물
JP6211380B2 (ja) * 2012-10-17 2017-10-11 丸善製薬株式会社 Ｔｉｅ２活性化剤、血管新生抑制剤、血管の成熟化剤、血管の正常化剤、及び血管の安定化剤
CN102934799B (zh) * 2012-11-16 2014-05-07 南京艾德凯腾生物医药有限责任公司 一种含蚕豆提取物的保健品及应用
CN104187624B (zh) * 2014-08-07 2016-06-08 逯明福 综合营养粉及其制备方法
KR102460344B1 (ko) 2015-09-08 2022-10-31 주식회사 케이오씨바이오텍 돌콩과 바나바잎 복합물을 포함하는 항당뇨 조성물
KR102624358B1 (ko) 2016-03-11 2024-01-12 주식회사 케이오씨바이오 돌콩 발효물을 유효성분으로 하는 당뇨병 및 당뇨합병증의 예방 및 치료를 위한 조성물
KR102133151B1 (ko) * 2019-03-28 2020-07-13 주식회사 노브메타파마 Chp(사이클로-히스프로)를 포함하는 복막 섬유증의 예방, 개선 또는 치료용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990066785A (ko) * 1997-10-02 1999-08-16 아처 다니엘 미드랜드 캄파니 이소플라본 제조 및 사용방법

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449665A (en) * 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
KR0151247B1 (ko) * 1994-11-09 1998-10-15 유상옥 비텍신과 이소비텍신을 함유하는 녹두 추출물 및 그의 제조방법
JPH0919276A (ja) * 1995-07-06 1997-01-21 Roozu Mei:Kk 健康美容飲料
PL184852B1 (pl) * 1996-02-29 2002-12-31 Nutri Pharma As Kompozycja na bazie składników soi
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6001368A (en) 1998-09-03 1999-12-14 Protein Technologies International, Inc. Method for inhibiting or reducing the risk of macular degeneration
DE19904352C1 (de) * 1999-02-03 2000-08-10 Indena Spa Lipide enthaltender Soja-Extrakt, Verfahren zu dessen Herstellung und pharmazeutische bzw. kosmetische Zusammensetzung sowie deren Verwendung zur Prävention oder Behandlung von trockener Haut
JP2002212080A (ja) * 2000-11-07 2002-07-31 Advanced Gene Technology Corp 抗血栓形成剤としてのアデノシン
US6838096B2 (en) 2001-06-20 2005-01-04 Taipei Veterans General Hospital Black soybean polysaccharides
KR20020029412A (ko) * 2002-03-29 2002-04-18 신승호 흰머리가 검어지는 효능을 가진 건강식품 및 그 제조방법.
CA2482464C (en) * 2002-04-18 2013-06-25 Monsanto Technology Llc Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
AU2002311198A1 (en) * 2002-04-24 2003-11-10 Toyo Shinyaku Co., Ltd. Process for producing proanthocyanidine-rich material
JP2004238289A (ja) * 2003-02-03 2004-08-26 Kikkoman Corp 血栓形成抑制剤及び機能性食品
CN100409851C (zh) * 2003-04-24 2008-08-13 沈阳药科大学 大豆异黄酮苷组合物及其制备方法和用途
JP2006016390A (ja) * 2004-06-04 2006-01-19 Toyo Shinyaku:Kk プロアントシアニジン含有組成物
JP5052011B2 (ja) * 2005-02-10 2012-10-17 株式会社東洋新薬 血流改善剤
JP2006225312A (ja) * 2005-02-17 2006-08-31 Fuji Oil Co Ltd レプチン分泌抑制組成物
JP2007106718A (ja) * 2005-10-14 2007-04-26 Sunstar Inc アディポネクチン分泌促進剤、並びにアディポネクチン分泌促進剤を含有する経口組成物。
KR100785466B1 (ko) * 2006-05-09 2007-12-13 (주)천년약속 검정콩으로부터 추출한 안토시아닌을 함유하는 의약 조성물
JP2006348049A (ja) * 2006-09-20 2006-12-28 Shirako:Kk 血管拡張による血流促進性医薬及び健康食品組成物
WO2008083513A1 (fr) * 2006-12-13 2008-07-17 Beijing Gingko-Group Biological Technology Co., Ltd. Extrait de pellicule de soja noir et procédé de préparation et d'utilisation de cet extrait

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990066785A (ko) * 1997-10-02 1999-08-16 아처 다니엘 미드랜드 캄파니 이소플라본 제조 및 사용방법

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIM, AE KYOUNG ET AL., J KOREAN SOC FOOD NUTR, vol. 37, no. 3, 2008, pages 302 - 308 *
OH, HAE SOOK ET AL., KOREAN J. FOOD SCI. TECHNOL., vol. 34, no. 3, 2002, pages 498 - 504 *
SHIN, MI KYEONG ET AL., J EAST ASIAN SOC DIETARY LIFE, vol. 16, no. 2, 2006, pages 165 - 173 *

Also Published As

Publication number Publication date
KR20170010885A (ko) 2017-02-01
JP2015163644A (ja) 2015-09-10
US11197903B2 (en) 2021-12-14
US20120070520A1 (en) 2012-03-22
JP6053871B2 (ja) 2016-12-27
US20190167745A1 (en) 2019-06-06
WO2010137875A2 (ko) 2010-12-02
KR101807619B1 (ko) 2017-12-11
CN102802652A (zh) 2012-11-28
KR101876471B1 (ko) 2018-07-16
JP2012528146A (ja) 2012-11-12
CN102802652B (zh) 2014-09-10
KR20100127728A (ko) 2010-12-06

Similar Documents

Publication Publication Date Title
WO2010137875A3 (ko) 콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물
WO2009001362A3 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
WO2011059755A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2011050262A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2011047262A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2011014659A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2010127284A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2010127294A3 (en) Dual variable domain immunoglobulins and uses thereof
SG178602A1 (en) Dual variable domain immunoglobulins and uses thereof
WO2006107745A3 (en) Composition for treatment of menopause
WO2009149189A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2009134776A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2009149185A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2012170807A3 (en) Anti-pseudomonas psl binding molecules and uses thereof
WO2006114775A3 (en) Treatment of insulin resistance syndrome
WO2011163319A3 (en) Activation of amp-protein activated kinase by oxaloacetate compounds
WO2009090394A3 (en) Composition containing capsicum for treating a skin disorder
MX2011012666A (es) Usos de anticuerpos il-1beta y sus fragmentos de union relacionados con eventos cardiovasculares.
WO2012033378A3 (ko) 비만억제 활성과 혈당강하 효능이 있는 꾸지뽕 및 의이인을 포함하는 조성물 및 이의 용도
WO2014096959A3 (en) Compositions and methods for treating or ameliorating obesity or for reducing diabetic hypercholesterolemia
WO2013025073A3 (ko) 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물
WO2011008947A3 (en) Treatment and diagnosis of immune disorders
WO2014064609A3 (en) HERBAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF TNF-α MEDIATED DISEASES
WO2009134021A3 (en) A composition of plants extract for alleviation of pruritus
MY155276A (en) Botanical extracts from oil palm vegetation liquor cosmeceutical applications

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080032432.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10780786

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 13322381

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2012512969

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10780786

Country of ref document: EP

Kind code of ref document: A2